Cleared Traditional

K821552 - PREG-KNOW

K821552 is an FDA 510(k) clearance for PREG-KNOW, manufactured by Immuno Pathology Labs. The device is a Class 2 Chemistry device with product code JHJ cleared through the Traditional 510(k) pathway after a 17-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1982
Decision
17d
Days
Class 2
Risk

K821552 is an FDA 510(k) clearance for the PREG-KNOW. Classified as Agglutination Method, Human Chorionic Gonadotropin (product code JHJ), Class II - Special Controls.

Submitted by Immuno Pathology Labs (Walker, US). The FDA issued a Cleared decision on June 11, 1982 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K821552

510(k) Number K821552 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 25, 1982
Decision Date June 11, 1982
Days to Decision 17 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 89d · This submission: 17d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHJ Device Classification - Class 2, Special Controls

Product Code JHJ Agglutination Method, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHJ Agglutination Method, Human Chorionic Gonadotropin

All 95
Devices cleared under the same product code (JHJ) and FDA review panel - the closest regulatory comparables to K821552.
HCG SCREENING TEST
K830156 · Tago, Inc. · Feb 1983
BETA FFIRM TEST
K823682 · Organon, Inc. · Jan 1983
PREG-PHILE B
K821676 · Bio Diagnostic Systems, Inc. · Jul 1982
PREG/TEX PREGNANCY TEST
K821387 · Texas Immunology, Inc. · Jun 1982
A-1 TEST
K812788 · C.F. Medical, Inc. · Dec 1981
ACU-SLIDE TEST
K812789 · C.F. Medical, Inc. · Dec 1981